Total Funding
31
46
Total FundingSeed raised
Growth Score
-6 pts
Heat Score
-33 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
134065
Cellebration Life Sciences offers research and treatments for autoimmune diseases and orthopedic injuries.
- Timothy Kopatich: Co-Founder and CEO
Bill Deegan: Co-Founder and Secretary/Treasurer
About the Company
Cellebration Life Sciences offers and administers stem-cell-based therapies specialized to treat specific degenerative conditions and directly target the area of concern in rejuvenation therapies. Cellebration Life Sciences currently has underway an FDA Clinical Trial application to develop a curative treatment for Type 2 Diabetes. The company is
also conducting further research to advance efforts to find permanent curative treatments for arthritis and other autoimmune diseases.
